Your browser doesn't support javascript.
loading
Corrigendum: Advanced NSCLC patients with EGFR T790M harbouring TP53 R273C or KRAS G12V cannot benefit from osimertinib based on a clinical multicentre study by tissue and liquid biopsy.
Fu, Yulong; Wang, Anqi; Zhou, Jieqi; Feng, Wei; Shi, Minhua; Xu, Xiao; Zhao, Hongqing; Cai, Liming; Feng, Jian; Lv, Xuedong; Zhang, Xiaodong; Xu, Wenjing; Zhang, Zhengrong; Ma, Guoer; Wang, Jian; Zhou, Tong; Zhao, Dahai; Fang, Haohui; Liu, Zeyi; Huang, Jian-An.
Afiliação
  • Fu Y; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Wang A; Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China.
  • Zhou J; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Feng W; Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China.
  • Shi M; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Xu X; Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China.
  • Zhao H; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Cai L; Department of Respiratory Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Feng J; Department of Respiratory Medicine, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
  • Lv X; Department of Respirology, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, China.
  • Zhang X; Department of Respiratory Medicine, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Xu W; Department of Respiratory Medicine, Affiliated Hospital of Nantong University, Nantong, China.
  • Zhang Z; Department of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong, China.
  • Ma G; Department of Medical Oncology, Nantong Tumor Hospital, Nantong, China.
  • Wang J; Departments of Respiratory Medicine, Northern Jiangsu People's Hospital, Clinical Medical College of Yangzhou University, Yangzhou, China.
  • Zhou T; Department of Respiratory Medicine, First People's Hospital of Yangzhou City, Yangzhou, China.
  • Zhao D; Department of Respiratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Fang H; Department of Respiratory Medicine, Zhenjiang First People's Hospital, Zhenjiang, China.
  • Liu Z; Department of Oncology, Changzhou Cancer Hospital Affiliated to Soochow University, Changzhou, China.
  • Huang JA; Department of Respiratory and Critical Care Medicine, The Second Hospital of Anhui Medical University, Hefei, China.
Front Oncol ; 13: 1236311, 2023.
Article em En | MEDLINE | ID: mdl-37441428
[This corrects the article DOI: 10.3389/fonc.2021.621992.].
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Suíça